mGluR-Homer interactions in excessive drinking

mGluR-Homer 与过量饮酒的相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Current theories of alcoholism posit that alcohol-induced neuroadaptations within limbic structures in the brain, including the nucleus accumbens (NAC), contribute to the transition from recreational alcohol drinking to excessive alcohol consumption. Recently, the Group 1 metabotropic glutamate receptor (mGluR) associated scaffolding protein Homer2 was identified as an active and necessary cellular mediator of alcohol-induced neural plasticity in mice. Constitutively expressed Homer proteins facilitate Group 1 mGluRstimulated intracellular signaling and cluster Group 1 mGluRs within the postsynaptic density, co-localizing these receptors with other proteins implicated in synaptic plasticity, such as PI3K (phosphatiylionsitol-3 kinase). Homer2 deletion reduces the function and the expression of Group 1 mGluRs in the NAC in vivo and the alcohol-avoiding and -intolerant behavioral phenotype of Homer2 knock-out (KO) mice resembles that produced by the pharmacological blockade of Group 1 mGluRs. Collectively, these observations suggest that Group 1 mGluR-Homer signaling is an important cellular mediator of excessive alcohol consumption. To test this hypothesis directly, this proposal will employ in vivo pharmacological and genetic approaches to characterize the role for Group 1 mGluR-Homer signaling within the NAC in regulating excessive alcohol consumption within the scheduled high alcohol consumption (SHAC) murine model (Aim 1). Immunohistochemical and immunoblotting approaches will be employed to determine the role for Homer2 n regulating the effects of sustained, excessive alcohol consumption upon the synaptic architecture of NAC neurons, as well as the formation, subcellular localization and function of mGluR-Homer signaling complexes (Aim 2). Finally, to relate genetic variance in excessive alcohol drinking to mGluR-Homer-PI3K expression and signaling within the NAC, immunoblotting the total protein content and membrane localization of members of the mGluR-Homer-PI3K signaling cascade will be compared between mouse lines selectively bred for high SHAC and SLAC (Scheduled Low Alcohol Consumption) phenotypes. The results of these studies will further our understanding of the cellular mechanisms involved in regulating the transition from recreational to excessive alcohol drinking and provide greater insight into the etiology of alcoholism and its treatment.
描述(由申请人提供):当前的酗酒理论认为,酒精诱导的大脑边缘结构(包括伏隔核(NAC))内的神经适应有助于从娱乐性饮酒到过度饮酒的转变。最近,1 类代谢型谷氨酸受体 (mGluR) 相关支架蛋白 Homer2 被确定为小鼠酒精诱导神经可塑性的活性且必需的细胞介质。组成型表达的 Homer 蛋白促进第 1 组 mGluR 刺激的细胞内信号传导,并将第 1 组 mGluR 在突触后密度内聚集,使这些受体与其他涉及突触可塑性的蛋白质(例如 PI3K(磷酸肌醇 3 激酶))共定位。 Homer2 缺失降低了体内 NAC 中第 1 组 mGluR 的功能和表达,Homer2 敲除 (KO) 小鼠的回避和不耐受行为表型与第 1 组 mGluR 的药理学阻断所产生的行为表型相似。总的来说,这些观察结果表明第 1 组 mGluR-Homer 信号传导是过度饮酒的重要细胞介质。为了直接检验这一假设,本提案将采用体内药理学和遗传学方法来表征 NAC 内第 1 组 mGluR-Homer 信号在调节预定高酒精消耗 (SHAC) 小鼠模型中过量饮酒中的作用(目标 1) 。将采用免疫组织化学和免疫印迹方法来确定 Homer2 n 对持续过量饮酒对 NAC 神经元突触结构的影响的调节作用,以及 mGluR-Homer 信号复合物的形成、亚细胞定位和功能(目标 2) )。最后,为了将过量饮酒的遗传变异与 NAC 内的 mGluR-Homer-PI3K 表达和信号传导联系起来,将在选择性繁殖的小鼠系之间比较 mGluR-Homer-PI3K 信号级联成员的总蛋白含量和膜定位的免疫印迹适用于高 SHAC 和 SLAC(计划性低酒精消耗)表型。这些研究的结果将进一步加深我们对调节从娱乐性饮酒到过度饮酒的转变所涉及的细胞机制的理解,并为酗酒的病因及其治疗提供更深入的了解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karen Kathleen Szumlinski其他文献

Karen Kathleen Szumlinski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karen Kathleen Szumlinski', 18)}}的其他基金

Incubated drug-craving and neurochemical interactions
潜伏的药物渴望和神经化学相互作用
  • 批准号:
    10543817
  • 财政年份:
    2021
  • 资助金额:
    $ 15.55万
  • 项目类别:
Incubated drug-craving and neurochemical interactions
潜伏的药物渴望和神经化学相互作用
  • 批准号:
    10181844
  • 财政年份:
    2021
  • 资助金额:
    $ 15.55万
  • 项目类别:
Incubated drug-craving and neurochemical interactions
潜伏的药物渴望和神经化学相互作用
  • 批准号:
    10391513
  • 财政年份:
    2021
  • 资助金额:
    $ 15.55万
  • 项目类别:
Adolescent Alcohol and Anxiety
青少年酒精与焦虑
  • 批准号:
    9056326
  • 财政年份:
    2016
  • 资助金额:
    $ 15.55万
  • 项目类别:
Homer-mediated signaling and cocaine addiction
荷马介导的信号传导和可卡因成瘾
  • 批准号:
    8274891
  • 财政年份:
    2008
  • 资助金额:
    $ 15.55万
  • 项目类别:
Homer-mediated signaling and cocaine addiction
荷马介导的信号传导和可卡因成瘾
  • 批准号:
    8078935
  • 财政年份:
    2008
  • 资助金额:
    $ 15.55万
  • 项目类别:
Homer-mediated signaling and cocaine addiction
荷马介导的信号传导和可卡因成瘾
  • 批准号:
    7686941
  • 财政年份:
    2008
  • 资助金额:
    $ 15.55万
  • 项目类别:
Homer-mediated signaling and cocaine addiction
荷马介导的信号传导和可卡因成瘾
  • 批准号:
    7591439
  • 财政年份:
    2008
  • 资助金额:
    $ 15.55万
  • 项目类别:
Homer-mediated signaling and cocaine addiction
荷马介导的信号传导和可卡因成瘾
  • 批准号:
    7845577
  • 财政年份:
    2008
  • 资助金额:
    $ 15.55万
  • 项目类别:
Molecular regulation of CeA glutamate and binge drinking
CeA 谷氨酸和酗酒的分子调控
  • 批准号:
    7894034
  • 财政年份:
    2006
  • 资助金额:
    $ 15.55万
  • 项目类别:

相似海外基金

PI3K Beta regulation of tumor metastasis
PI3K Beta 对肿瘤转移的调节
  • 批准号:
    10408965
  • 财政年份:
    2022
  • 资助金额:
    $ 15.55万
  • 项目类别:
Non-canonical roles for ATM kinase in regulating mitochondrial function and redox homeostasis
ATM 激酶在调节线粒体功能和氧化还原稳态中的非典型作用
  • 批准号:
    10461498
  • 财政年份:
    2022
  • 资助金额:
    $ 15.55万
  • 项目类别:
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies
研究非共价布鲁顿酪氨酸激酶抑制剂的耐药机制以及克服 B 细胞恶性肿瘤患者耐药性的治疗方法
  • 批准号:
    10537252
  • 财政年份:
    2022
  • 资助金额:
    $ 15.55万
  • 项目类别:
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
吡格列酮-二甲双胍联合治疗高危口腔癌前病变
  • 批准号:
    10390245
  • 财政年份:
    2022
  • 资助金额:
    $ 15.55万
  • 项目类别:
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy
用于 TNBC 特异性联合治疗的完全基于蛋白质的自组装纳米平台
  • 批准号:
    10668398
  • 财政年份:
    2022
  • 资助金额:
    $ 15.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了